SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-001423
Filing Date
2024-08-13
Accepted
2024-08-13 16:31:12
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q g084373_10q.htm   iXBRL 10-Q 1183436
2 EXHIBIT 31.1 g084373_ex31-1.htm EX-31.1 13101
3 EXHIBIT 32.1 g084373_ex32-1.htm EX-32.1 7771
  Complete submission text file 0001753926-24-001423.txt   5175637

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE chro-20240630.xsd EX-101.SCH 45021
5 XBRL CALCULATION FILE chro-20240630_cal.xml EX-101.CAL 33511
6 XBRL DEFINITION FILE chro-20240630_def.xml EX-101.DEF 145680
7 XBRL LABEL FILE chro-20240630_lab.xml EX-101.LAB 368094
8 XBRL PRESENTATION FILE chro-20240630_pre.xml EX-101.PRE 239393
51 EXTRACTED XBRL INSTANCE DOCUMENT g084373_10q_htm.xml XML 724897
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41964 | Film No.: 241202190
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)